Last updated on February 2008

Sorafenib Long Term Extension Program (STEP)


Brief description of study

This study will enable patients receiving sorafenib (Nexavar) in the completed Bayer/Onyx sponsored clinical trials to continue treatment. During the entire course of the study, numerous patients will be treated with sorafenib. Involvement in this study will be depending on whether the patient benefits from the treatment or not, based on the physician's judgment and the results of particular additional examinations. Overall, participation in this study will help to evaluate the safety and efficacy of treatment with sorafenib.

Clinical Study Identifier: NCT00625378

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Los Angeles, CA United States
  Connect »

Bayer Clinical Trials Contact

New Haven, CT United States
  Connect »

Bayer Clinical Trials Contact

Philadelphia, PA United States
  Connect »

Bayer Clinical Trials Contact

Nashville, TN United States
  Connect »

Bayer Clinical Trials Contact

San Antonio, TX United States
  Connect »

Bayer Clinical Trials Contact

Charlottesville, VA United States
  Connect »

Bayer Clinical Trials Contact

Bruxelles - Brussel, Belgium
  Connect »

Bayer Clinical Trials Contact

Floridablanca-Bucaramanga, Colombia
  Connect »

Bayer Clinical Trials Contact

Wellington South, New Zealand
  Connect »

Bayer Clinical Trials Contact

Hospitalet de Llobregat, Spain
  Connect »

Bayer Clinical Trials Contact

Southampton, United Kingdom
  Connect »